Discovery of new, highly potent and selective inhibitors of BuChE - design, synthesis, in vitro and in vivo evaluation and crystallography studies-Reference-Cited by-同舟云学术

Discovery of new, highly potent and selective inhibitors of BuChE - design, synthesis, in vitro and in vivo evaluation and crystallography studies

Published:2023-03 Issue: Volume:249 Page:115135
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Panek Dawid,Pasieka Anna,Latacz Gniewomir,Zaręba Paula,Szczęch Michał,Godyń Justyna,Chantegreil Fabien,Nachon Florian,Brazzolotto Xavier,Skrzypczak-Wiercioch Anna,Walczak Maria,Smolik Magdalena,Sałat Kinga,Höfner Georg,Wanner Klaus,Więckowska Anna,Malawska Barbara

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference53 articles.

1. Alzheimer's disease;Scheltens;Lancet (London, England),2016

2. Selective loss of central cholinergic neurons in Alzheimer's disease;Davies;Lancet (London, England),1976

3. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease;Hampel;Brain,2018

4. A second wind for the cholinergic system in Alzheimer's therapy;Douchamps;Behav. Pharmacol.,2017

5. Butyrylcholinesterase and the cholinergic system;Reid;Neuroscience,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current pharmacophore based approaches for the development of new anti-Alzheimer’s agents;Bioorganic & Medicinal Chemistry;2024-09

2. DESIGN, SYNTHESIS, AND BIOLOGICAL ASSESSMENT OF NOVEL N'-(BENZYLIDENE)PROPANEHYDRAZIDES AS MTDL FOR ALZHEIMER’S DISEASE;Ankara Universitesi Eczacilik Fakultesi Dergisi;2024-06-25

3. Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases;ACS Chemical Neuroscience;2024-04-22

4. Synthesis and investigation of the cholinesterase inhibitory and antioxidant capacities of some novel N'‐(quinolin‐4‐ylmethylene)propanehydrazides against Alzheimer's disease;Drug Development Research;2024-04-16

5. Discovery, Structure-Based Modification, In Vitro, In Vivo, and In Silico Exploration of m-Sulfamoyl Benzoamide Derivatives as Selective Butyrylcholinesterase Inhibitors for Treating Alzheimer’s Disease;ACS Chemical Neuroscience;2024-03-07